New Label Could Fix Medicaid’s Insulin Pen Misstep
Don’t Tie Clinicians’ Hands on Gout Prescriptions
Why Health Care Providers Should Care About ICER
Alliance for Patient Access
Another State Calls it Quits with Pharmacy Benefit Managers
Can ICER Put a Value on Diabetes Management?
Uncertainty Plagues ICER Report on Type 2 Diabetes
Federal Trade Commission Stands with Patients on “Bad Drug” Ads
Prior Authorization Delays Treatment & Increases Rx Steroid Use
Diabetes, Deductibles & the IRS
High Out-of-Pocket Costs: A Position Statement
